Prednisone, Methotrexate, and Cyclophosphamide for Autoimmune Inner Ear Disease

This study focuses on a condition called Autoimmune Inner Ear Disease (AIED), which causes rapid hearing loss in both ears. The goal is to test if certain drugs - prednisone, methotrexate, and cyclophosphamide - can effectively treat this condition. AIED is believed to be triggered by the body's own immune system attacking the inner ear, and these drugs are used to control this process due to their strong anti-inflammatory properties. The study is important as it aims to find a treatment for AIED, potentially improving the quality of life for those affected by this condition. The study is conducted in an outpatient setting and is in its Phase III. Participants are divided into four groups, each testing a different combination of the drugs. The study lasts for 18 months and requires a minimum of 11 visits from each participant. During this time, the effectiveness of the drugs in treating AIED is evaluated. The study does not mention specific potential risks, but the use of strong anti-inflammatory drugs is typically monitored closely to ensure patient safety.